Abstract:AbstractDirectly measuring evidence of influenza infections is difficult, especially in low surveillance settings such as sub-Saharan Africa. Using a Bayesian model, we estimated unobserved infection times and underlying antibody responses to influenza A/H3N2 using cross-sectional serum antibody responses to four strains in children aged 24-60 months. Among the 242 individuals, we estimated a variable seasonal attack rate and found that most children had at leas… Show more
“…However, many milder cases (including outpatients) are included in the reports as they may seek healthcare at the hospital, thereby increasing the expected reporting rate in this context. Overall therefore, our model estimates fit the data well, as well as known aspects of influenza and RSV transmission, such as high influenza attack rates in children 31,32 , and higher RSV severity in the youngest children 33 .…”
Influenza and Respiratory Syncytial Virus (RSV) interact within their host posing the concern for heterologous ecological changes following vaccination. We aimed to estimate the population level impact of their interaction.
We developed a dynamic age-stratified two-pathogen mathematical model that includes pathogen interaction through competition for infection and enhanced severity of dual infections. We used parallel tempering to fit it's parameters to 11 years of enhanced hospital-based surveillance for acute respiratory illnesses (ARI) in children under 5 years old in Nha Trang, Vietnam.
The data supported either a 41% (95%CrI: 36 - 54) reduction in heterologous acquisition during infection and for 10.0 days (95%CrI 7.1 -12.8) thereafter, or no cross protection. We estimate that co-infection increased the probability for an infection in <2y old children to be reported 7.2 fold (95%CrI 5.0 - 11.4); or 16.6 fold (95%CrI 14.5 - 18.4) in the respective scenarios. Absence of either pathogen was not to the detriment of the other.
We find stronger evidence for severity enhancing than for acquisition limiting interaction. In this setting vaccination against either pathogen is unlikely to have a major detrimental effect on the burden of disease caused by the other.
“…However, many milder cases (including outpatients) are included in the reports as they may seek healthcare at the hospital, thereby increasing the expected reporting rate in this context. Overall therefore, our model estimates fit the data well, as well as known aspects of influenza and RSV transmission, such as high influenza attack rates in children 31,32 , and higher RSV severity in the youngest children 33 .…”
Influenza and Respiratory Syncytial Virus (RSV) interact within their host posing the concern for heterologous ecological changes following vaccination. We aimed to estimate the population level impact of their interaction.
We developed a dynamic age-stratified two-pathogen mathematical model that includes pathogen interaction through competition for infection and enhanced severity of dual infections. We used parallel tempering to fit it's parameters to 11 years of enhanced hospital-based surveillance for acute respiratory illnesses (ARI) in children under 5 years old in Nha Trang, Vietnam.
The data supported either a 41% (95%CrI: 36 - 54) reduction in heterologous acquisition during infection and for 10.0 days (95%CrI 7.1 -12.8) thereafter, or no cross protection. We estimate that co-infection increased the probability for an infection in <2y old children to be reported 7.2 fold (95%CrI 5.0 - 11.4); or 16.6 fold (95%CrI 14.5 - 18.4) in the respective scenarios. Absence of either pathogen was not to the detriment of the other.
We find stronger evidence for severity enhancing than for acquisition limiting interaction. In this setting vaccination against either pathogen is unlikely to have a major detrimental effect on the burden of disease caused by the other.
“…There is limited information on the attack rate of seasonal HCoV, however there have been numerous studies looking at influenza. Previous systematic reviews have estimated the attack rate of influenza to be between 3.5% and 22.5% [26][27][28] , whilst modelling studies have estimated this to be higher, 20 -60% 29,30 . Based on reporting rates of seasonal HCoV we would expect the attack rate to be lower than influenza.…”
Section: Discussionmentioning
confidence: 99%
“…There is little information on the attack rate of HCoVs, but there have been several systematic reviews and meta-analyses looking at unvaccinated individuals which have reported the attack rate to range between 15.2% -22.5% in children and 3.5% -10.7% in adults [26][27][28] . Modelling studies using serological influenza data predicted estimates from 20 -60% 29,30 . We expect the attack rate for HCoV may be lower based on the epidemiology of these viruses in children 31 , but we selected a prior which covers a range of plausible values.…”
Background: The duration of immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still uncertain, but it is of key clinical and epidemiological importance. Seasonal human coronaviruses (HCoV) have been circulating for longer and, therefore, may offer insights into the long-term dynamics of reinfection for such viruses. Methods: Combining historical seroprevalence data from five studies covering the four circulating HCoVs with an age-structured reverse catalytic model, we estimated the likely duration of seropositivity following seroconversion. Results: We estimated that antibody persistence lasted between 0.9 (95% Credible interval: 0.6 - 1.6) and 3.8 (95% CrI: 2.0 - 7.4) years. Furthermore, we found the force of infection in older children and adults (those over 8.5 [95% CrI: 7.5 - 9.9] years) to be higher compared with young children in the majority of studies. Conclusions: These estimates of endemic HCoV dynamics could provide an indication of the future long-term infection and reinfection patterns of SARS-CoV-2.
“…However these were not greatly different, with the medians of the two priors only differing by 3.6% and therefore not substantially different to help us distinguish between the two modes. Overall therefore, our model estimates fit the data well, as well as known aspects of influenza and RSV transmission, such as high influenza attack rates in children [46,47], and higher RSV severity in the youngest children [48].…”
Influenza and Respiratory Syncytial Virus (RSV) interact within their host posing the concern for impacts on heterologous viruses following vaccination. We aimed to estimate the population level impact of their interaction. We developed a dynamic age-stratified two-pathogen mathematical model that includes pathogen interaction through competition for infection and enhanced severity of dual infections. We used parallel tempering to fit its parameters to 11 years of enhanced hospital-based surveillance for acute respiratory illnesses (ARI) in children under 5 years old in Nha Trang, Vietnam. The data supported either a 41% (95%CrI: 36–54) reduction in susceptibility following infection and for 10.0 days (95%CrI 7.1–12.8) thereafter, or no change in susceptibility following infection. We estimate that co-infection increased the probability for an infection in <2y old children to be reported 7.2 fold (95%CrI 5.0–11.4); or 16.6 fold (95%CrI 14.5–18.4) in the moderate or low interaction scenarios. Absence of either pathogen was not to the detriment of the other. We find stronger evidence for severity enhancing than for acquisition limiting interaction. In this setting vaccination against either pathogen is unlikely to have a major detrimental effect on the burden of disease caused by the other.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.